For our next Readers' Review: "Go Set A Watchman." You've heard about the mystery surrounding its publication, you’ve read the reviews: Now we give you a chance to weigh in on this new release by Harper Lee.
An FDA advisory board recommended withdrawing government approval for the breast cancer drug, Avastin. Pros and cons of the decision and its implications for FDA’s accelerated approval process to treat serious and life threatening diseases.
- Gardiner Harris science reporter for "The New York Times" and author of the mystery novel 'Hazard.'
- Dr. Peter Bach attending physician and director of the Center for Health Policy and Outcomes at Memorial Sloan-Kettering Cancer Center, and a former adviser to Medicare.
- Dr. Carolyn Hendricks a medical oncologist affiliated with Suburban Hospital in Bethesda.
- William Hubbard former associate commissioner for the Food and Drug Administration; spokesperson for the Alliance for a Stronger FDA
Most Recent Shows
Islamic State militants have blown up the ancient temple of Baalshamin in Palmyra and beheaded a renowned antiquities scholar. We look at recent atrocities by ISIS and the terror group’s broader strategy for power.
The authors of a recent article in The Atlantic argue that political correctness on college campuses is not only harming education — it's also harming students themselves. We look at the debate and how it's affecting the way we learn and teach.
Ongoing fears of a slowdown in the Chinese economy drive a stock sell-off and declines in commodity prices worldwide. We look at what the global market downturn could mean for the U.S. economy, businesses and consumers.